Pseudohypoaldosteronism
Pseudohypoaldosteronism, also known as Cheek-Perry syndrome, was first reported by Cheek and Perry (1958) and is a rare salt-losing syndrome. It is currently believed that the cause of this disease is the lack of aldosterone receptors on the patient's target organs (renal tubules, salivary glands, sweat glands and colon), or the reduced or complete inability of aldosterone to bind to its receptors.
-
Site of disease:
Kidney blood vessels -
Infectious :
Not contagious -
Frequent population:
All groups -
Related symptoms:
Polyuria Nausea and vomiting Abdominal pain with nausea and vomiting Dehydration fever Loss of thirst -
Concurrent disease:
Related Drugs
Compound Mannitol Injection
Indication: Used to reduce intracranial pressure, intraocular pressure, diuresis and prevent and treat renal failure.
Manufacturer:
Hubei Duorui Pharmaceutical Co., Ltd.
Sodium chloride
Indication: Water loss due to various reasons, including hypotonic, isotonic and hypertonic water loss; hyperosmotic non-ketotic diabetic coma, hypochloremic metabolic alkalosis; external use of normal saline for flushing eyes and washing wounds, etc.; also used for water bag induction of labor in obstetrics.
Related Ingredients